Fluorescent focus reduction assay for the screening of antiadenoviral agents

Journal of Virological Methods

Volumn 59, Issue 1-2, 1996, Pages 99-104

  Mentel, Renate ^a   Matthes, Eckard ^b   Janta Lipinski, Martin ^b   Wegner, Ursula ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Adenovirus; Focus reduction assay; Inhibition of virus replication; Modified nucleoside analogs

Indexed keywords

ADENOVIRUS; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; COLORIMETRY; DNA DETERMINATION; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 0029891801     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02026-5     Document Type: Article

References (13)

1. Gordon, Y.J., Romanowski, F., Aroullo-Cruz, T. and De Clercq, E. (1992) Pretreatment with topical 0.1% (5)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model, Cornea 11, 529-533.
2. Hui, M.B.V., Lien, E.J. and Trousdale, M.D. (1994) Inhibition of human adenoviruses by 1-(2′hydroxy-5′-methoxybenzylidene) amino-3-hydroxyguanidine tosylate. Antiviral Res. 24, 261-273.
3. Jernigan, A.J., Lowry, B.S., Hayden, F.G., Kyger, S.A., Conway, B.P., Gröschel, D.H.M. and Farr, B.M. (1993) Adenovirus type 8 epidemic keratoconjuntivitis in an eye clinic: risk factors and control. J. infect. Dis. 167, 1307-1313.
4. Little, J.M., Lorenzetti, D.W.C., Brown, D.C., Schweem, H.H., Jones, B.R. and Kaufman, H.E. (1968) Studies of adenovirus type 3 infection treated with methisazone and trifluorothymidine. Proc. Soc. Exp. Biol. Med. 127, 1028-1032.
5. Mc Laren, C., Ellis, M.N. and Hunter, G.A. (1983) A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 3, 223-234.
6. Matthes, E., Lehmann, C., Scholz, D., Janta-Lipinski, M., Gaertner, K., Langen, P. and Rosenthal, H.A. (1987) Fluorierte nucleoside Verfahren zu ihrer Herstellung und ihrer Verwendung als pharmazeutische Mittel gegen AIDS. EP 0254268A2.
7. Meisel, H., Reimer, K., Janta-Lipinski, M., Bärwolff, D. and Matthes, E. (1990) Inhibition of hepatitis B-virus DNA-polymerase by 3′-fluorothymidine nucleoside triphosphate and other modified nucleoside triphosphate analogs. J. Med. Virol. 301, 137-141.
8. Mentel, R., Jacker, S. and Wegner, U. (1993) Studies on the developement of an adenovirus infection model in hamsters. Hyg. Med. 18, 489-493.
9. Philipson, L., Lonberg-Holm, K. and Petterson, U. (1968) Virus-receptor interaction in an adenovirus system a. J. Virol. 2, 1064-1075.
10. Shields, A.F., Hackmann, R.C., Fyte, K.H., Corey, L. and Meyers, J.D. (1985) Adenovirus infection in patients undergoing bone-marrow transplantation. N. Engl. J. Med. 312, 529-533.
11. Thiel, J.F. and Smith, K.O. (1967) Fluorescent focus assay of viruses on cell Monolayer in plexi petri plates. Proc. Soc. Exp. Biol. Med. 125, 892-895.
12. Tsai, J.C., Garlinghouse, G., McDonnell, P.J. and Trousdale, M.D. (1992) An experimental model of adenovirus induced ocular disease: the cotton rat. Arch. Ophthalmol. 110, 1670-1170.
13. Watanabe, W., Koume, K., Jjichi, K., Inoue, H., Yokota, T. and Shigeta, S. (1994) MTT colorimetric assay system for the screening of antiorthomyxo-and antiparamyxoviral agents. J. Virol. Methods 48, 257-265.